Volume 3, Issue 2-1, March 2015, Page: 18-21
Evaluation of Antimicrobial Activity of Curcumin Against Two Oral Bacteria
Najah A. Mohammed, Medical technology institute, Medical technical university (MTU), Baghdad, Iraq
Neama Y. Habil, Medical technology institute, Medical technical university (MTU), Baghdad, Iraq
Received: Dec. 21, 2014;       Accepted: Dec. 25, 2014;       Published: Jan. 27, 2015
DOI: 10.11648/j.acis.s.2015030201.14      View  3748      Downloads  380
Oral pathogenic gram-positive bacteria, Streptococcus pyogenes (Strept.pyogenes) are caused severe human diseases with complications, including rheumatic fever, sepsis, severe soft-tissue invasion, and toxic-shock-like syndrome (TSLS). Whereas, Streptococcus mutants(Strept. mutans),described a key causative agent of caries and infective endocarditis. Therefore, the aim of this study was to evaluate the inhibitory effect of Curcumin on Strept. mutans and Strept.pyogenes growth in comparison with the antibiotic Ciprofloxacin using well diffusion method. Minimum Inhibitory Concentration (MICs) showed that curcumin-mediated growth inhibition of Strept. mutans and, Strept. pyogenes. Results showed that curcumin significantly inhibitedthe activity of Strept. mutans and Strept. pyogenes growth with inhibition zones, 9.7mm and 10.2 mm, respectively while the inhibition zone of Ciprofloxacin 15.52mm to 13.4mm against Strept. mutans, Strept. pyogenes respectively.The antimicrobial activity of curcumin on Strept. mutans and Strept. pyogenes growth suggests that the curcumin may be useful for controlling dental biofilms, subsequently dental caries formation.This study provides significant insights into the therapeutic effect of curcumin against pathogenic gram positive bacteria, suggesting its potential as an alternative therapy, and opens the way for further studies on identification of novel antimicrobial targets of curcumin.
Curcumin, Antibacterial Activity, Minimum Inhibitory Concentration (MIC)
To cite this article
Najah A. Mohammed, Neama Y. Habil, Evaluation of Antimicrobial Activity of Curcumin Against Two Oral Bacteria, Automation, Control and Intelligent Systems. Special Issue: Artificial Nano Sensory System. Vol. 3, No. 2-1, 2015, pp. 18-21. doi: 10.11648/j.acis.s.2015030201.14
Chen, Y. R. & Tan, T. H. (1998). Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene, 17, 173-178.
Han, K.-H., Azuma, S. & Fukushima, M.( 2014). In vitro fermentation of spent turmeric powder with a mixed culture of pig faecal bacteria. Food & Function.
Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Sung, B., Tharakan, S. T., Misra, K., Priyadarsini, I. K., Rajasekharan, K. N. & Aggarwal, B. B.( 2008). Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochemical Pharmacology, 76, 1590-1611.
Beck, J., Garcia, R., Heiss, G., Vokonas, P. S. & Offenbacher, S.( 1996). Periodontal Disease and Cardiovascular Disease. Journal of Periodontology, 67, 1123-1137.
Scannapieco, F. A. (1999). Role of Oral Bacteria in Respiratory Infection. Journal of Periodontology, 70, 793-802.
Kafaru E. (1994) Immense Help Formative Workshop. In: Essential. Pharmacology, 1st edn. pp.11-14. Elizabeth Kafaru Publishers, Lagos, Nigeria. 125.
Jason M. Tanzer, Streptococcus salivarius FruA Inhibits Streptococcus mutans biofilm formation. Journal of Dental Research vol.74, pp:1536 (1995).
Jones, G., and Moellering R.C. (2004) Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin. Infect. Dis . 46 Suppl 5: 360-367.
Evans, C.E., A. Banso and O.A. Samuel. (2002) Efficacy of some medicinal plants against Salmonella typhi: an in vitro study. J. Ethnopharmacology.80:21-24.
Ahmad I, Mehamood Z, Mohammad F. (1998). Screening of some Indian medicinal plants for their antimicrobial properties. J. Ethnopharmacol. 62: 183-193.
Clark A.M. (1996). Natural products as resource for new drugs. Phar. Res., 13:1133-1141.
Cordell G.A.(2009).Biodiversity and drug discovery a symbiotic relationship. Phytochemistry, 55:463-480.
Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK (2004).Turmeric and curcumin: Biological actions and medicinal applications.Curr. Sci. 87: 44-53.
Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007). Curcumin: the Indian solid gold. Adv. Exp. Med. Biol. 595: 1-75. Brooks GF.
Di Mario F, Cavallaro LG, Nouvenne A, Stefani N, Cavestro GM, Lori V, Maino M, Comparato G, Fanigliulo L, Morana E, Pilotto A, Martelli L, Martelli M, Leandro G, Franze A (2007). A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter, 12: 238-243. [IVSL].
Menon VP, Sudheer AR (2007). Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 595: 105-125.
Panesar, P. S., Kumari, S. & Panesar, R. (2013). Biotechnological approaches for the production of prebiotics and their potential applications. Critical Reviews in Biotechnology, 33, 345-364.
Habil, N., Abate, W., BEAL, J. & Foey, A. D. (2012). Lactobacillus casei strain Shirota selectively modulates macrophage subset cytokine production. Int. J. Probiotics & Prebiotics 7(1), 1-12..
Habil, N., Abate, W., BEAL, J. & Foey, A. D. ( 2011). Probiotic bacterial strains differentially modulate macrophage cytokine in a strain-depent and cell subset-specific manner. Beneficial Microbe, 2(4), 283-293.
Habil, N., Abate, W., BEAL, J. & Foey, A. D. (2014). Heat-killed probiotic bacteria differentially regulate colonic epithelial cell production of human β-defensin-2: dependence on inflammatory cytokines. Beneficial Microbes, 5, 483-495
Eigner D, Scholz D. (1999). Ferula asa-foetidaand Curcuma longa in traditional medical treatment and diet in Nepal. J Ethnopharmacol. 67:1–6.
Majeed M, Badmaev V, Shivakumar U, Rajendran R. (1995).Curcuminoids Antioxidant Phytonutrients. Nutriscience Publishers, Inc. Pisctway New Jersey USA.
Chattopadhyay I., Biswas K., Bandyopadhyay,U. and Banerjee R.K.(2004). Turmeric and curcumin: Biological actions and medicinal applications. Curr. Sci., 87: 44-53.
Mohammadi K, Thompson KH, Patrick BO, Storr T, Martins C, Polishchuk E, Yuen VG, McNeill JH, Orvig C (2005). Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. J. Inorg. Biochem. 99: 2217-2225.
Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS. (2009).Chemopreventive Effect of Curcumin, a Naturally Occurring Anti-Inflammatory Agent, during the Promotion/Progression Stages of Colon Cancer. Cancer Res; 59:597-601.
Bansod S., and Rai M.(2009). Antimicrobial Activity of Essential Oils from Indian Medicinal Plants against Human Pathogens. World Journal of Medical Sciences, 3 (2): 81-88.
Pandit, Santosh; Kim, Hye-Jin; Kim, Jeong-Eun; Jeon, Jae-Gyu (2011). Separation of an effective fraction from turmeric against Streptococcus mutans biofilms by the comparison of curcuminoid content and anti-acidogenic activity. Food Chemistry 126 (4): 1565–70.
Hadacek F and Greger H. (2007). Testing of antifungal natural products: methodologies, comparability of results and assay choice. Phytochem. Analys. 11: 137-147.
Bauer, A. W.; Kirby, M (1966). Antibiotic Susceptibility testing by standard disc method. Am. J. Clin. Patho. 10, 45; 493-496.
Junior, A. and Zanil, C. (2006). Biological screening of Brazilian meditional plants. Braz. J. Sci. 95: 367-373.
CLSI, (2009). Methods for dilution of antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard 5th ed. CLSI document; M07-A8. (ISBN 1-56238-689-1).
Shahi, S. K., Shukla, A. C., Bajaj, A. K., Banerjee, U., Rimek, D., Midgely, G., and Dikshit, A. (2000). Broad spectrum herbal therapy against superficial fungal infections.SkinPharmacolAppl Skin Physiol. 13(1):60-64.
Qa'dan, F. Thewaini, A. Ali D. Afifi R, Elkhawad A. and . Matalka KZ. (2005). The antimicrobial activities of Psidiumguajava and Juglansregia leaf extracts to acne-developing organisms. The American Journal of Chinese Medicine, 33: 197–204.
Browse journals by subject